G. Kozmetsky


tions and firms. American firms have initiated a continuing stream of
high-technology products to be manufactured overseas.
 One of the hallmarks of the U.S. States federal megaproject research
programs in the 1980s (SDI and space station) has been to seek and attain
cooperative research efforts with our allies. These cooperative actions have
served to share research costs, diffuse technology, provide for increasing
productivity, and expand real incomes of foreign nations. In addition, they
have provided subsequent benefits to our own citizens in advanced tech-
nology and lower costs, as well as alternative choices of products.
 John A. Young, Chairman of the President's National Commission on
Industrial Competitiveness, in his testimony before the U.S. House Sub-
committee on Economic Stabilization, stated that "the ability of American
industry to compete against foreign competitors, both at home and
abroad, is central to our attainment of just about any other goal." He
added, "The loss of American leadership in technology markets should
have grave consequences for the entire economy since its application is the
essential ingredient in the improvement of nearly every industry."


 U.S. BIOTECHNOLOGY COMPETITIVE LEADS

 The United States scientific explorations in the increasingly competitive
fields of biotechnology have been, to this point in time, one of worldwide
leadership. There is little question that the United States holds the world's
competitive lead in the scientific competition for biotechnology.
 Cutting-edge technologies such as those found in biotechnology are the
primary drivers for creating newer products and services, as well as emerg-
ing industries. Among the industries that will be most directly affected by
biotechnology research are:

 1. Pharmaceuticals
 2. Agriculture
 3. Chemical
 4. Energy
 5. Mining
 6. Pollution Control
 7. Food Processing
 8. Biotechnology R&D Support and Supply
 9. Consulting
 10. Biotechnology Capital Goods
 11. Health Care